MRI-Guided radiation: a sharper aim for HPV cancers?

NCT ID NCT03634267

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tests whether using MRI scans to guide the placement of internal radiation (brachytherapy) can improve treatment for women with advanced cervical or vaginal cancers linked to HPV. The study involves 26 participants and compares MRI-guided placement to standard ultrasound or freehand methods. The goal is to see if MRI helps deliver a more precise radiation dose to the tumor while sparing nearby organs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Internal radiation therapy (brachytherapy) guided by MRI

What this could lead to

If successful, this approach could make brachytherapy more precise, potentially improving tumor control and reducing side effects for women with cervical or vaginal cancer.

What could go wrong

This is a very early phase 1 trial with only 26 participants, so results may not apply to all patients. The technique requires MRI-compatible equipment and may not be feasible for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma human papillomavirus-related squamous cell carcinoma Uterine Cervical Neoplasms vaginal cancer vaginal carcinoma vaginal squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States